Skip to main content
SpringerLink
Log in
Book cover

The Treatment of Hodgkin’s Disease pp 43–67Cite as

Clinical Management of Hodgkin’s Disease

  • Chapter

  • 35 Accesses

Abstract

In recent years a certain balance of opinion has been reached with respect to the management of the protean forms of this disease. The benefits of more modern forms of therapy are generally acknowledged and uniform treatment patterns have emerged. Results can be anticipated with greater certainty and prognosis is more accurate (Karnofsky et al., 1966). An important aspect of planned treatment is that damage is avoided and the patients’ immunological status is unimpaired, since these factors are of essential importance in the determination of survival times.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Ahmann, D. L., J. M. Kiely, G. H. Harrison, and W. S. Payne: Malignant lymphoma of the spleen. Cancer 19, 461 (1966).

    Article  PubMed  CAS  Google Scholar 

  • Aisenberg, A. C.: Manifestations of immunologic unresponsiveness in Hodgkin’s disease. Canc. Res. 26, 1152 (1966).

    CAS  Google Scholar 

  • Anaveri, G., e M. Lucherini: La malattia di Hodgkin. Nuntius Radiol. 12, 1323 (1964).

    Google Scholar 

  • Anglesio, E.: Trattamento della malattia di Hodgkin con il Natulan. Min. med. 56, 4402 (1965).

    CAS  Google Scholar 

  • Anglesio, E.: The treatment of systemic lymphomas with chlorambucil. Proc. VII. Congr. Intern. Soc. Haematology, Rome 1958.

    Google Scholar 

  • Anglesio, E., A. Carbonara, and G. Mancini: Study of serum proteins in malignant lymphomas (in press).

    Google Scholar 

  • Arends, T., C.V. Conrad, and R. W. Rundles: Serum proteins in Hodgkin’s disease and malignant lymphomas. Amer. J. Med. 16, 833 (1964).

    Article  Google Scholar 

  • Armstrong, J. G., R. W. Dyke, P. J. Fouts, and J. E. Gahimer: Hodgkin’s disease, carcinoma of the breast and other tumors treated with Vinblastine sulfate. Canc. Chem. Report 18, 49 (1962).

    CAS  Google Scholar 

  • Backhouse, T. W., and K. Sicher: Initial experiences with Methylhydrazine, a new cytotoxic agent. Clin. Rad. 17, 132 (1966).

    Article  CAS  Google Scholar 

  • Bacq, Z. M., and P. Alexander: Fundamentals of radiobiology. 2nd Ed. Oxford: Pergamon Press 1961.

    Google Scholar 

  • Barbieri, D.: Quoted by Ferrata e Storti.

    Google Scholar 

  • Barry, R. M., H. D. Diamond, and L. F. Craver: Influence of pregnancy on the course of Hodgkin’s disease. Amer. J. Obst. Gyn. 84, 445 (1962).

    CAS  Google Scholar 

  • Bernard, J.: Principes généraux actuels du traitement de la maladie de Hodgkin, des lymphosarcomes, des réticuloses. Rev. Pract. 16, 871 (1966).

    CAS  Google Scholar 

  • Bernard, J., G. Mathé et M. Weil: Traitement par l’acide P(di-2-chloro-éthylamino)phenilbutyrique de la maladie de Hodgkin, etc. Sang 28, 80 (1957).

    PubMed  CAS  Google Scholar 

  • Berneis, K., W. Bollag, M. Kofler, and H. Lüthy: Synergismus between jonising radiation and a cytotoxic methylhydrazine derivative: effect on DNA-degradation. Experientia 21, 318 (1965).

    Article  PubMed  CAS  Google Scholar 

  • Bichel, J.: Some investigations on the mechanism of the leukopenia produced by Vincaleucoblastine. Acta path. micr. scand. 67, 1 (1966).

    CAS  Google Scholar 

  • Bichel, J. Hodgkin’s disease and pregnancy. Acta rad. 33, 427 (1950).

    Article  CAS  Google Scholar 

  • Bichel, J. Hodgkin’s disease of the oesophagus. Acta rad. 35, 371 (1951).

    Article  CAS  Google Scholar 

  • Biesele, J. J.: Mitotic poisons and the cancer problem. Amsterdam: Elsevier 1958.

    Google Scholar 

  • Bjerre Hansen, P., and J. Bichel: Triethylene melamine therapy in Hodgkin’s and other malignant diseases. Acta rad. 35, 469 (1951).

    Article  Google Scholar 

  • Bollag, W.: The tumor-inhibitory effects of the methylhydrazine derivative Ro 4–6467/1. Cancer Chem. Report 33 (1963).

    Google Scholar 

  • Bonazi, C. F.: Enfermedad de Hodgkin y embarazo. Prens. med. Argent. 45, 2378 (1958).

    Google Scholar 

  • Bond, W. H., R. J. Rohn, R. W. Dyke, and P. J. Fouts: Clinical use of triethylenemelamine. Report of 75 cases. Arch. int.Med. 91, 577 (1959).

    Google Scholar 

  • Bostick, W. L.: Evidence for the virus etiology of Hodgkin’s disease. Ann. N. Y. Acad. Sc. 73, 307 (1958).

    Article  CAS  Google Scholar 

  • Bousser, J.: Aspects cliniques de la maladie de Hodgkin et des sarcomes ganglionnaires. Rev. Pract. 16, 819 (1966).

    CAS  Google Scholar 

  • Brunner, K. W., and C. W. Young: A methylhydrazine derivative in Hodgkin’s disease and other malignant neoplasms. Ann. int. Med. 63, 69 (1965).

    PubMed  CAS  Google Scholar 

  • Bunting, C. H., and J.L. Yates: An etiologic study of Hodgkin’s disease. J. Amer. med. Ass. 61, 1803 (1913).

    Article  Google Scholar 

  • Buschke, F.: Hodgkin’s disease: Indication for radiation therapy. J. Amer. med. Ass. 191, 317 (1965).

    Article  CAS  Google Scholar 

  • Calciati, A., e M. Fazio: Intradermo-test con tubercolina deposito nel linfogranuloma maligno. Min. Med. 52, 3359 (1961).

    CAS  Google Scholar 

  • Chase, M. W.: Delayed-type hypersensitivity and the immunology of Hodgkin’s disease, with a parallel examination of sarcoidosis. Canc Res. 26, 1097 (1966).

    CAS  Google Scholar 

  • Chevallier, P., et G. Bilski-Pasquier: Maladie de Hodgkin ou Lymphgranulomatose maligne Traité de Médecine. Paris: Masson & Cie 1949.

    Google Scholar 

  • Chiappa, S.: La radioterapia endolinfatica nel trattamento delle linforeticolopatie sistemiche. J. Belge Radiol. 47, 657 (1964).

    PubMed  CAS  Google Scholar 

  • Chiappa, S., G. Bonadonna, C. Uslenghi, G. Galli, P. Marano, and A. Molinari: Current views and recent results on endolymphatic radiotherapy in the treatment of malignant lymphomas. (In press).

    Google Scholar 

  • Cohen, N., and J. W. Canter: Hodgkin’s disease of the small intestine: report of six cases. Amer. J. Digest Dis. 4, 361 (1959).

    Article  CAS  Google Scholar 

  • Congdon, Ch. C.: The destructive effect of radiation on lymphatic tissue. Canc. Res. 26, 1211 (1966).

    CAS  Google Scholar 

  • Cook, J. C., K. L. Krabbenhoft, and T. Leucutia: Combined radiation and nitrogen mustard therapy in Hodgkins’ disease as compared with radiation therapy alone. Amer. J. Roentgen. 82, 651 (1959).

    PubMed  CAS  Google Scholar 

  • Cornes, J. S.: Hodgkin’s disease of the gastro-intestinal tract. Proc. roy. Soc. Med. 60, 732 (1966).

    Google Scholar 

  • Craver, L. F.: Recent advances in treatment of lymphomas, leukemias and allied disorders. Bull. N. Y. Acad. Med. 24, 3 (1948).

    PubMed  CAS  Google Scholar 

  • Craver, L. F.: Treatment of Hodgkin’s disease. Treament of cancer and allied diseases. New York: Harper and Row 1964.

    Google Scholar 

  • Croizat, P., et R. Creyssel: Les troubles des protéines du sérum dans les hémopathies malignes. Rev. Pract. 11, 587 (1961).

    CAS  Google Scholar 

  • Croizat, P., et R. Creyssel, P. Galy, J. Papillon, L. Revol, J. L. Chassard et G. Bretagnolle: Les formes mediastinals de debut de la maladie de Hodgkin. J. Radiol. 43, 1 (1942).

    Google Scholar 

  • Cuccioli, U.: Su di una localizzazione primitiva esofagea del linfogranuloma maligno. Arch. ital. Mal. Appar. dig. 27, 150 (1960).

    PubMed  CAS  Google Scholar 

  • D’Alessandri, A., H. J. Keel, W. Bollag u. G. Martz: Erste klinische Erfahrungen mit einem neuen Cytostaticum. Schweiz. med. Wschr. 93, 1018 (1963).

    PubMed  Google Scholar 

  • Dameshek, W., L. Weissfuse, and T. Stein: Nitrogen mustard therapy in Hodgkin’s disease: analysis of 50 consecutive cases. Blood 4, 338 (1949).

    PubMed  CAS  Google Scholar 

  • Dawson, I. M. P., I. S. Cornes, and B.C. Morson: Primary malignant lymphoid tumors of the intestinal tract. Brit. J. Surg. 49, 80 (1961).

    Article  PubMed  CAS  Google Scholar 

  • Dawson, P. S., and C. V. Harrison: A clinicopathological study of benign Hodgkin’s disease. J. clin. Path. 14, 219 (1961).

    Article  PubMed  CAS  Google Scholar 

  • Dayan, A. D., H. G. Morgan, H. F. Hope-Stone, and B. J. Boucher: Disseminated Herpes Zoster in the reticuloses. Amer. J. Roentg. 92, 116 (1964).

    CAS  Google Scholar 

  • Del Vecchio, S., e C. Sandomenico: La terapia radiante del linfogranuloma maligno. Rev. Radiol. 6, 1191 (1966).

    Google Scholar 

  • De Vita, V. T., and A. Serpick: Combination chemotherapy in the treatment of advanced Hodgkin’s disease. Proc. Amer. Ass. Canc. Res. 8, 49 (1967).

    Google Scholar 

  • Devois, A., et R. Decker: L’avenir de la maladie de Hodgkin traitée. Sem. Hôp. 30, 197 (1954).

    PubMed  CAS  Google Scholar 

  • De Vries, S. I.: Treatment of malignant lymphomas with chlorambucyl. Acta haemat. 19, 1 (1958).

    Article  Google Scholar 

  • Diamond, H. D.: Results of therapy in Hodgkin’s disease. Ann. N. Y. Acad. Sci. 73, 357 (1958).

    Article  PubMed  CAS  Google Scholar 

  • Di Guglielmo, R., A. Miliani, V. Lombardi, F. Zini e A. Zilli: Effect clinici e umorali indotti dalla terapia con prednisone a dosi elevate in alcune emopatie e altre situazioni morbose. Haemat. 46, 309 (1961).

    Google Scholar 

  • Di Pietro, S.: Risultati a distanza di 100 casi di malattia di Hodgkin trattati con chemoterapia. Tumori 53, 111 (1967).

    PubMed  Google Scholar 

  • Di Pietro, S., e L. V. Giacomelli: Le ipriti azotate e la chemioterapia dei tumori maligni. Tumori 40 (1954).

    Google Scholar 

  • DiPietro, S., e C. Uslenghi: Primi risultati della radioterapie endolinfatica nel linfogranuloma maligno. Tumori 51, 113 (1965).

    PubMed  CAS  Google Scholar 

  • DiPietro, S., e F. Pizzetti: La prognosi istologica del granuloma maligno in base allo studio di 100 casi. Tumori 52, 451 (1966).

    CAS  Google Scholar 

  • Dubin, I. N.: Poverty of immunological mechanism in patients with Hodgkin’s disease. Ann. int. Med. 27, 898 (1947).

    PubMed  CAS  Google Scholar 

  • Dubois-Ferrière, H.: Le traitement actuel des leucémies aigues et des lymphomes malins en stade de généralization. Méd. Hyg. (Genève) 16, 464 (1964).

    Google Scholar 

  • Easson, E. C.: Possibilities for the cure of Hodgkin’s disease. Cancer 19, 345 (1966).

    Article  Google Scholar 

  • Easson, E. C., and M. H. Russell: The cure of Hodgkin’s disease. Brit. med. J. i, 1704 (1963).

    Article  Google Scholar 

  • Ebner, H., u. J. Söltz-Szöts: Generalisierter Herpes Zoster bei Morbus Hodgkin. Zschr. Haut- u. Geschl.-Kr. 41, 85 (1966).

    CAS  Google Scholar 

  • End Result Group: Mortality trends in cancer. N. C. I. monography n. 6 (1961).

    Google Scholar 

  • Ennuyer, A., P. Bataini et J. Hèlary: Maladie de Hodgkin des voies aéro-digestives supérieures. Ann. Oto-laryng. 78, 474 (1961).

    Google Scholar 

  • Estevez, R. A.: Use of mannitol derivative of nitrogen mustard. Sem. Med. 125, 281 (1964).

    CAS  Google Scholar 

  • Fairley, G. H., M. J. L. Pasterson, and R.B. Scott: Chemotherapy of Hodgkin’s disease with cyclophosphamide, vinblastine and procarbazine. Brit. med. J. ii, 75 (1966).

    Article  Google Scholar 

  • Fauvet, J., et J. Roujeau: Les dérivés cortisoniques dans le traitement du cancer et de la lymphogranulomatose maligne. Rev. Pract. 10, 2405 (1960).

    CAS  Google Scholar 

  • Fazio, M., P. Cavallero, S. Sartoris, F. Vergnana e L. Pegarolo: Prime esperienze cliniche con metilidrazina nel trattamento del linfogranuloma maligno. Min. Med. 56, 99 (1965).

    Google Scholar 

  • Felci, U.: Terapia radiologica dei tumori linforeticolari. Atti Soc. It. Cancerologia, Milano 1967.

    Google Scholar 

  • Ferrata, A., e E. Storti: Le malattie del sangue. Milano: Vallardi 1958.

    Google Scholar 

  • Forbus, W. D., and J. U. Gunter: Pathogenicity of strains of brucella obtained from case of Hodgkin’s disease. South. med. J. 34, 376 (1941).

    Article  Google Scholar 

  • Flury, R., u. T. Wegmann: Das Verhalten der alkalischen Leukocytenphosphatase beim morbus Hodgkin. Schweiz. med. Wschr. 94, 958 (1964).

    PubMed  CAS  Google Scholar 

  • Fuller, L. M.: Results of large volume irradiation in the management of Hodgkin’s disease and malignant lymphomas originating in the abdomen. Radiology 87, 1058 (1966).

    PubMed  CAS  Google Scholar 

  • Fuller, L. M., and G. H. Flechter: The radiotherapeutic management of the lymphomatous diseases. Amer. J. Roentg. 88, 909 (1962).

    CAS  Google Scholar 

  • Fuller, L. M., B. Jing, C. C. Schullenberger, and J.J. Butler: Radiotherapeutic management of Hodgkin’s disease involving the mediastinum. Proc. roy. Soc. Med. 60, 730 (1966).

    Google Scholar 

  • Gall, E. A.: The surgical treatment of malignant lymphoma. Ann. Surg. 118, 1064 (1966).

    Article  Google Scholar 

  • Galton, D. A. G., L.G. Israels, J. D. M. Nabarro, and A.M. Till: Clinical trials of P(di-2-chlorethylamino)phenylbutiric acid (C.B. 1348) in malignant lymphomas. Brit. med. J. ii, 1172 (1955).

    Article  Google Scholar 

  • Galton, D. A. G., L.G. Israels, J. D. M. Nabarro, M. Till, and E. Wiltshaw: Busulfan (1,4-dimethansulfonoxibutane)Myleran. Summary of clinical results. Ann. N. Y. Acad. Sci. 68, 967 (1958).

    Article  PubMed  CAS  Google Scholar 

  • Gamna, C., e F. Piino: Il linfogranuloma maligno gastro-intestinale. Arch. ital. Mal. Apper. dig. 8, 312 (1939).

    Google Scholar 

  • Gary-Bobo, J.: Premiers résultats des traitements par la Vincaleucoblastine des maladies de système et des sarcomes (association à la radiothérapie). Antitumoral effects of Vinca Rosea Alkaloids. Amsterdam: Excerpta Medica Found. 1966.

    Google Scholar 

  • Geller, W.: The mandate for chemotherapeutic decompression in superior vena caval obstruction. Radiol. 81, 387 (1963).

    Google Scholar 

  • Geller, W., and M. J. Lacher: Hodgkin’s disease. Med. Clin. N. Amer. 50, 819 (1966).

    PubMed  CAS  Google Scholar 

  • Gellhorn, A.: Management of the patients with Hodgkin’s disease. J. chron. Dis. 1, 698 (1955).

    Article  PubMed  CAS  Google Scholar 

  • Gellhorn, A.: End results in lymphosarcoma and Hodgkin’s disease. Proc. 3rd Nat. Canc. Conf. Philadelphia: Lippincott 1957.

    Google Scholar 

  • Gellhorn, A., and V.P. Collins: A quantitative evaluation of the contribution of nitrogen mustard to the therapeutic management of Hodgkin’s disease. Ann. int. Med. 35, 1250 (1951).

    PubMed  CAS  Google Scholar 

  • Gerhartz, H.: Clinical results with cyclophosphamide and trisethylene iminoquinone. In: Plattner: Chemotherapy of cancer. Amsterdam: Elsevier 1964.

    Google Scholar 

  • Gilbert, R.: The problem of pregnancy in Hodgkin’s disease. Acta radiol. 35, 71 (1961).

    Google Scholar 

  • Goldman, I. M., and I. R. Hobbs: The immunoglobulins in Hodgkin’s disease. Immunology 13, 421 (1967).

    PubMed  CAS  Google Scholar 

  • Goodman, L. S., M. M. Wintrobe, W. Dameshek, M. J. Goodman, A. Gilman, and M. T. McLennan: Nitrogen mustard therapy. Use of methyl-bis(β-chloroethyl)-amine hydrochloride and tris (β-chloroethyl) -amine hydrochloride for Hodgkin’s disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders. J. Amer. med. Ass. 132, 126 (1946).

    Article  CAS  Google Scholar 

  • Goulian, M., and J. L. Fahey: Abnormalities in serum proteins and protein bound exose in Hodgkin’s disease. J. Lab. clin. Med. 57, 408 (1961).

    PubMed  CAS  Google Scholar 

  • Grace, J. T., and A. Mittelman: Surgery in the management of Hodgkin’s disease. Cancer 19, 351 (1966).

    Article  Google Scholar 

  • Gremmel, H.: Die primäre Lymphogranulomatose des Magens. Die Med. 24, 977 (1958).

    Google Scholar 

  • Grifoni, V., S. Tognella, G. Bignotti, A. Forni, G. Gasparini e C. Confalonieri: Stato attuale della terapia della malattia di Hodgkin. Rec. Prog. Med. 39, 585 (1965).

    CAS  Google Scholar 

  • Grollman, A., R.L. Johnson, and W.W. Regan: A clinical evaluation of colchicine in the treatment of Hodgkin’s disease. Ann. int. Med. 42, 154 (1955).

    PubMed  CAS  Google Scholar 

  • Gross, R., u. K. Lambers: Erste Erfahrungen in der Behandlung maligner Tumoren mit einem neuen N-Lost-Phosphamidester. Dtsch. med. Wschr. 83, 458 (1958).

    Article  PubMed  CAS  Google Scholar 

  • Hall, C. A., and K. B. Olson: Prognosis of the malignant lymphomas. Ann. int. Med. 44, 687 (1956).

    PubMed  CAS  Google Scholar 

  • Hammer, B.: Ergebnisse radiologisch-zytostatischer Kombinationsbehandlung maligner Erkrankungen. Wien. med. Wschr. 117, 637 (1967).

    PubMed  CAS  Google Scholar 

  • Hammer, B.: Zur Behandlung des Lymphogranuloms. Wien. med. Wschr. 116, 562 (1966).

    PubMed  CAS  Google Scholar 

  • Hampel, K. E., D. Algenstaedt u. H. Gerhatz: Zur Butazolidinbehandlung menschlicher Hämoblastosen. Blut 7, 398 (1961).

    Article  PubMed  CAS  Google Scholar 

  • Han, T., and L. Stutzman: Mode of spread in patients with localized malignant lymphoma. Arch. int. Med. 120, 1 (1967).

    Article  CAS  Google Scholar 

  • Hancock, P. E. T., and E. M. Ledlie: Treatment of early Hodgkin’s disease. Lancet i, 26 (1967).

    Article  Google Scholar 

  • Hansen, M. M., H. Hertz, and A. Videbaek: Use of a methylhydrazine derivative especially in Hodgkin’s disease. Acta med. scand. 180, 211 (1966).

    Article  PubMed  CAS  Google Scholar 

  • Hanson, T. A. S.: Histological classification and survival in Hodgkin’s disease. Cancer 17, 1595 (1964).

    Article  PubMed  CAS  Google Scholar 

  • Hare, H. F., B. M. Dahle, and J.G. Trump: Two million-volt X-ray therapy of Hodgkin’s disease. Ann. N. Y. Acad. Sc. 73, 363 (1958).

    Article  CAS  Google Scholar 

  • Harder, J.: Über Knochenlymphogranulomatose. Fortschr. Röntgenstr. 93, 445 (1960).

    Article  CAS  Google Scholar 

  • Heynal, A., u. F. Regli: Neurologische Symptome bei Morbus Hodgkin. Schweiz. med. Wschr. 94, 1515 (1964).

    Google Scholar 

  • Healy, R. J., H. I. Arnery, and M. Friedman: Hodgkin’s disease: a review of two hundred and sixteen cases. Radiology 64, 51 (1955).

    PubMed  CAS  Google Scholar 

  • Heilmeyer, L., u. K. Musshoff: Die Therapie der Lymphogranulomatose und die Frage ihrer Heilbarkeit. Münch. med. Wschr. 109, 2109 (1967).

    PubMed  CAS  Google Scholar 

  • Hennessy, J. P., and A. Rottino: Hodgkin’s disease in pregnancy. Amer. J. Obst. Gyn. 87, 851 (1963).

    CAS  Google Scholar 

  • Hill, J. M., and E. Loeb: Treatment of leukemia, lymphoma and other malignant neoplasms with vinblastine. Canc. Chemother. Rep. 15, 41 (1961).

    CAS  Google Scholar 

  • Hodgkin, Th.: One some morbid appearances of the absorbent glands and spleen. Medico-Chir. Trans. 17, 68 (1832).

    CAS  Google Scholar 

  • Hoffbrand, B. I.: Hodgkin’s disease and hypogammaglobulinemia, a rare association. Brit. med. J. i, 1156 (1964).

    Article  Google Scholar 

  • Hohl, K.: Heutiger Stand der Therapie und Prognose der Lymphogranulomatose. Radiol. Clin. 33, 273 (1964).

    Google Scholar 

  • Hohl, K., Ph. Sarasin u. W. Bessler: Therapie und Prognose der Lymphogranulomatose. Oncologia 4, 1 (1951).

    Article  PubMed  CAS  Google Scholar 

  • Horwich, L., P. H. Buxton, and M.S. Ryan: Cerebellar degeneration with Hodgkin’s disease. J. Neurol. Neurosurg. Psychiat. 29, 45 (1951).

    Article  Google Scholar 

  • Hoskins, E. O. L.: Unusual radiological manifestations of Hodgkin’s disease. Proc. roy. Soc. Med. 60, 729 (1966).

    Google Scholar 

  • Hultberg, S.: Pregnancy in Hodgkin’s disease. Acta radiol. 41, 277 (1957).

    Google Scholar 

  • Israels, L. G., D. Galton, M. Till, and E. Wilshaw: Clinical evaluation of CB 1348 in malignant lymphoma and related diseases. Ann. N. Y. Acad. Sci. 68, 915 (1958).

    Article  PubMed  CAS  Google Scholar 

  • Jackson, A.: Primary Hodgkin’s disease of the stomach. Amer. J. Surg. 94, 546 (1957).

    Article  PubMed  CAS  Google Scholar 

  • Jackson, F. C., E. G. Ney, and E.R. Fisher: Surgical implantation of Hodgkin’s disease of the stomach to the skin of the abdominal wall. Ann. Surg. 150, 1000 (1959).

    Article  PubMed  CAS  Google Scholar 

  • Jackson, H., and F. Parker: Hodgkin’s disease and allied disorders. New York: Oxford Univ. Press 1947.

    Google Scholar 

  • Jacobson, L. O., C. L. Spurr, E. S. Guzman Borron, T. Smith, C. Lushbough, and G. F. Dick: Nitrogen mustard therapy. Studies on the effect of methyl-bis(β-chloroethyl)amine hydrochloride on neoplastic disease and allied disorders of the hemopoietic system. J. Amer. med. Ass. 132, 263 (1946).

    Article  CAS  Google Scholar 

  • Jeliffe, A. M.: Facteurs influant sur la survie à long terme des malades atteints de maladie de Hodgkin. Nouv. Rev. franç. Haemat. 7, 85 (1966).

    Google Scholar 

  • Jeliffe, A. M.: Factors in early cancer which influence the prognosis: Hodgkin’s disease. Proc. roy. Soc. Med. 59, 605 (1966).

    Google Scholar 

  • Jeliffe, A. M., and A. D. Thompson: The prognosis in Hodgkin’s disease. Brit. J. Cancer 9, 21 (1955).

    Article  Google Scholar 

  • Kandoshchuk, T. A., and A. E. Kucherenko: Diagnostic difficulties in localized Hodgkin’s disease of the gastrointestinal tract. Klin. Chir. 4, 9 (1964).

    Google Scholar 

  • Kane, A. A.: Hodgkin’s disease of the stomach. Amer. J. Gastroent. 40, 504 (1963).

    PubMed  CAS  Google Scholar 

  • Kaplan, H. S.: The radical radiotherapy of regionally localised Hodgkin’s disease. Radiology 78, 553 (1962).

    PubMed  CAS  Google Scholar 

  • Kaplan, H. S.: Evidence of a tumoricidal dose level in the radiotherapy of Hodgkin’s disease. Canc. Res. 26, 1221 (1966).

    CAS  Google Scholar 

  • Kaplan, H. S.: Role of intensive radiotherapy in the management of Hodgkin’s disease. Cancer 19, 356 (1966).

    Article  Google Scholar 

  • Kaplan, H. S.: Clinical evaluation and radiotherapic management of Hodgkin’s disease and malignant lymphomas. New Engl. J. Med. 278, 892 (1968).

    Article  PubMed  CAS  Google Scholar 

  • Karnofsky, D. A.: The staging of Hodgkin’s disease. Canc. Res. 26, 1090 (1966).

    CAS  Google Scholar 

  • Karnofsky, D. A.: Chemotherapy of Hodgkin’s disease. Cancer 19, 371 (1966).

    Article  Google Scholar 

  • Karnofsky, D. A.: Hodgkin’s disease: Chemotherapy. J. Amer. med. Ass. 191, 30 (1965).

    Article  CAS  Google Scholar 

  • Karnofsky, D. A., J. K. Burchenal, G. C. Armstead, C. M. Southam, J. L. Bernstein, L. F. Craver, and C. P. Rhoads: Triethylene melamine in the treatment of neoplastic disease. Arch. int. Med. 87, 477 (1951).

    Article  CAS  Google Scholar 

  • Karnofsky, D. A., D. G. Miller, and R.F. Phillips: Role of chemotherapy in the management of early Hodgkin’s disease. Amer. J. Roentgenol. 90, 968 (1963).

    PubMed  CAS  Google Scholar 

  • Kaufman, G.: Hodgkin’s disease involving central nervous system. Arch. Neur. 13, 555 (1965).

    Article  CAS  Google Scholar 

  • Keel, H. J., W. Roth, G. Keiser, F. Reuer u. G. Martz: Über das Zusammentreffen von Morbus Hodgkin’ und Toxoplasmose. Schweiz. med. Wschr. 93, 1465 (1963).

    PubMed  CAS  Google Scholar 

  • Keiser, G., K. Brunner u. G. Martz: Klinische Erfahrungen mit VLB (Velbé) einem neuem Cytostaticum. Schweiz. med. Wschr. 92, 486 (1962).

    PubMed  CAS  Google Scholar 

  • Kenis, Y.: Etude comparée de la Vincaleucoblastine et du Natulan dans la maladie de Hodgkin. Antitumoral effects of Vinca Rosea Alkaloids. Amsterdam: Excerpta Medica Found 1966.

    Google Scholar 

  • Kenis, Y., J. Werli, J. H. Hildebrand et H. J. Tagnon: Action d’un derivé de la methylhydrazine, le Ro 4.6467, dans la maladie de Hodgkin, dans d’autres lymphomes malins et dans les leucémies. Europ. J. Cancer 1, 33 (1965).

    CAS  Google Scholar 

  • Kolár, J., u. J. Kácl: Zur Diagnostik von malignen Lymphomen des Magen-Darm-Kanals. Med. Klin. 53, 140 (1958).

    Google Scholar 

  • Kopp, H., u. R. Heineker: Zur Behandlung von bösartigen Lymphknotentumoren mit Cyclophosphamid. Dtsch. med. Wschr. 90, 1257 (1965).

    Article  Google Scholar 

  • Krumbhaar, E. B.: The presetn status of Hodgkin’s disease. Symposium on the blood and blood-forming organs. Wisconsin Univ. press: Madison 1939.

    Google Scholar 

  • Kuentz, M.: Etude statistique, clinique et thérapeutique de la granulomatose maligne. A propos de 170 observ. Thèse de Lyon 1955.

    Google Scholar 

  • Kummer, H., u. U. Bucher: Erfahrungen mit einem neuen Zytostaticum der Methylhydrazinreihe (Natulan.) Schweiz. Med. Wschr. 95, 31, 1233 (1965).

    PubMed  CAS  Google Scholar 

  • Kundrat, H.: Ueber Lympho-sarkomatosis. Wien. klin. Wschr. 6, 211 (1893).

    Google Scholar 

  • Kuzma, I., J. Jancina, and J. Durkowsky: Therapeutic results in mediastinal localization of lymphogranulomatosis. Neoplasma 13, 185 (1966).

    PubMed  CAS  Google Scholar 

  • Kyle, R. A., C. E. McParland, and W. Dameshek: Large doses of prednisone and prednisolone in treatment of malignant lymphoproliferative disorders. Ann. int. Med. 57, 717 (1962).

    PubMed  CAS  Google Scholar 

  • Lacher, M. J.: Role of surgery in Hodgkin’s disease. New Engl. J. Med. 268, 289 (1963).

    Article  PubMed  CAS  Google Scholar 

  • Lane, M., B. Lipowska, Th. C. Hall, and J. Calsky: A preliminary report: observations on the clinical pharmacology of 5[bis(2-chloroethyl)amino](uracil mustard: MSC 34 462). Canc. Chemother. Report 9, 31 (1960).

    Google Scholar 

  • Larionov, L. F.: Immediate and remote results of chloroethylamine treatment of Hodgkin’s disease. Brit. med. J. i, 252 (1956).

    Article  Google Scholar 

  • Laszlo, J., J. Grizzl, U. Jonsson, and R. W. Rundles: Comparative study of mannitol mustard, cyclophosphamide and nitrogen mustard in malignant lymphomas. Canc. Chemother. Report 16, 247 (1962).

    CAS  Google Scholar 

  • Lee, B.J.: Lymphangiography in Hodgkin’s disease: indications and controindications. Canc. Res. 26, 1084 (1966).

    CAS  Google Scholar 

  • Leng-Lévy, J., J. David-Chaussé, B. Leng, P. Magendie et M. Bellet: Les formes coelomiques de la maladie de Hodgkin. J. Méd. Bordeaux 143, 1727 (1966).

    PubMed  Google Scholar 

  • Leonardi, P., e L. Menozzi: Sul valore semeiologico e clinico dello Zoster nelle emoblastosi. Acta med. patav. 18, 185 (1958).

    Google Scholar 

  • Lettré, H.: Action of vincaleucoblastine upon cells in vitro and against Ehrlich ascites tumours. Antitumoral effects of Vinca Rosea Alkaloids. Excerpta Med. Found.: Amsterdam 1966.

    Google Scholar 

  • Levitt, W. M.: Large-volume radiotherapy. Brit. J. Radiol. 28, 75 (1955).

    Article  PubMed  CAS  Google Scholar 

  • Linke, A.: Die Behandlung der Haemoblastosen und der bösartigen Geschwülste mit Trisethylen Iminobenzokinon. Dtsch. med. Wschr. 85, 1928 (1960).

    Article  PubMed  Google Scholar 

  • Lobell, M., D. R. Boggs, and M. M. Wintrobe: The clinical significance of fever in Hodgkin’s disease. Arch. int. Med. 117, 335 (1966).

    Article  Google Scholar 

  • Longcope, W. T., and K. R. McAlpin: Hodgkin’s disease. Oxford Med. 4, part. 1 (1920).

    Google Scholar 

  • Longo, P., e V. Beltrami: Linfogranuloma di Hodgkin a localizzazione principale splenica. (Possibilità e limiti della splenectomia.) Ann. Fac. Med. Chir. Perugia 49, 179 (1958).

    Google Scholar 

  • Lukes, R.J.: Relationship of histologic features to clinical stages in Hodgkin’s disease. Amer. J. Roentgenol. 90, 944 (1963).

    PubMed  CAS  Google Scholar 

  • Lukes, R.J.: Prognosis and relationship of histologic features to clinical stages. J. Amer. med. Ass. 190, 914 (1966).

    Article  Google Scholar 

  • Maggiorelli, L., G. Faleg e A. Pazzagli: Patologia del granuloma maligno nei vari distretti del canale alimentare. Arch. De Vecchi 30, 147 (1959).

    PubMed  CAS  Google Scholar 

  • Magrassi, F.: Quoted by Ferrata e Storti.

    Google Scholar 

  • Marchal, G., L. Mallet et G. Duhamel: Traitement de la maladie de Hodgkin. Paris: Doin & Cie. 1956.

    Google Scholar 

  • Marcolongo, R., e C. A. Boggiano: Sull’azione antipiretica della’indometacin nel linfogranuloma di Hodgkin e nelle neoplasie. Min. Med. 57, 2857 (1966).

    CAS  Google Scholar 

  • Marmont, A., e F. A. Fusco: Una nuova sostanza antiblastica, la vincaleucoblastina nel trattamento delle emolinfoblastosi. La Clin. Ter. 25, 301 (1964).

    Google Scholar 

  • Marsden, J. A.: Report on the use of vincaleucoblastine in the cases of Hodgkin’s disease. Med. J. Austr. 2, 100 (1963).

    Google Scholar 

  • Marsden, J. A., and E. E. Damasio: Studies on the effects of two alkaloids from Vinca Rosea on human malignant cells in vivo. I. The effects of vinblastine in Hodgkin’s disease. Proc. 10th Congr. Europ. Soc. Haematology, Strasburg 1965.

    Google Scholar 

  • Marshall, S. F., and N. E. Adamson: Sarcoma of the stomach. Surg. Clin. North Amer. 39, 711 (1959).

    CAS  Google Scholar 

  • Martz, G., A. D’Alessandri, J. Keel, and W. Bollag: Preliminary clinical results with a new antitumor agent, Ro 4–6467. Canc. Chemother. Report 33, 5 (1963).

    CAS  Google Scholar 

  • Mathé, G., L. Berumen, O. Schweissguth, M. Schneider, J. L. Amiel, A. Cattan, L. Schwarzenberg et G. Brule: Essai de traitement par une méthylhydrazine de la maladie de Hodgkin et de divers hématosarcomes et leucémies. Presse méd. 72, 1641 (1964).

    PubMed  Google Scholar 

  • Mathé, G., M. Schneider, P. Bond, J. L. Amiel, L. Schwarzenberg, A. Cattan et J. R. Schlumberger: Leurosine sulfate (NSC 90 636) in treatment of Hodgkin’s disease, acute lymphoblastic leukemia and lymphoblastic lymphosarcoma. Canc. Chemother. Report 49, 47 (1965).

    Google Scholar 

  • Mathé, G., O. Schweissguth, G. Brulé, J. L. Amiel, A. Cattan, M. Thomas et P. Zamet: Essai de traitement de la maladie de Hodgkin et d’autres affections réticulohystiocytaires malignes par la Vincaleucoblastine. Presse méd. 70, 1349 (1962).

    PubMed  Google Scholar 

  • Mauro, G., e V. Prato: L’herpes zoster nelle leucemie e nel linfogranuloma. Min. Med. 48, 2954 (1957).

    CAS  Google Scholar 

  • McNeer, G., and G. T. Pack: Malignant tumors of the stomach. In: Pack and Ariel: Treatment of cancer and allied diseases. New York: Hober 1962.

    Google Scholar 

  • Melli, G., e V. Grifoni: Terapia delle emoblastosi. Atti 61° Cong. Medicina Interna, Napoli 1960.

    Google Scholar 

  • Miller, D. G., H. D. Diamond, and L. F. Craver: The clinical use of chlorambucil. A critical study. New Engl. J. Med. 261, 525 (1959).

    Article  PubMed  CAS  Google Scholar 

  • Minet, P.: Grossesse et Lymphogranulomatose maligne. Etude de sept cas d’association. Presse méd. 69, 1617 (1961).

    PubMed  CAS  Google Scholar 

  • Moeschlin, S.: Langzeitbehandlung der Hämoblastosen. Dtsch. med. J. 17, 551 (1960).

    Google Scholar 

  • Monahan, D. T.: Hodgkin’s disease of the lung. J. thorac. cardiovasc. Surg. 49, 172 (1965).

    Google Scholar 

  • Mouvet, W.: Les localisations gastriques des „Lymphomes malins“. J. Belge Radiol. 43, 553 (1960).

    PubMed  CAS  Google Scholar 

  • Mussa, L.: Il trattamento radiante del morbo di Hodgkin. Giorn. Accad. Med. Torino 130, 294 (1967).

    Google Scholar 

  • Musshoff, K., M. Busch u. H. Kaminski: Lymphogranulomatose (Morbus Hodgkin) mit Knochenbefall etc. Fortschr. Röntgenstr. 101, 117 (1964).

    Article  CAS  Google Scholar 

  • Nagy, E., and K. Meszaros: Experiences with Degranol in the treatment of mycosis fungoides. Magyar. Onkol. 4, 57 (1960).

    Google Scholar 

  • Nice, C. N., and K. W. Stenstrom: Irradiation therapy in Hodgkin’s disease. Radiol. 62, 641 (1954).

    CAS  Google Scholar 

  • Obrecht, P., G. Mössner, H. Strickstrock u. W. J. Woenckhaus: Die Therapie der Lymphogranulomatose und des Retikulosarcoms mit dem Zytostaticum Velbe. Beitr. Inn. Med. Stuttgart: Schattauer 1964.

    Google Scholar 

  • Obrecht, P., K. H. Strickstrock u. H. Weibleder: Klinische und lymphographische Verlaufskontrolle bei Lymphogranulomatose und Retothelsarcom unter Behandlung mit Natulan. Europ. J. Cancer 2, 59 (1966).

    CAS  Google Scholar 

  • Osgood, E. E.: Methods of analysing survival data illustrated by Hodgkin’s disease. Amer. J. Med. 24, 40 (1958).

    Article  PubMed  CAS  Google Scholar 

  • Pack, G. T., and D. W. Molander: The surgical treatment of Hodgkin’s disease. Canc. Res. 26, 1254 (1966).

    CAS  Google Scholar 

  • Pagliardi, E., and E. Giangrandi: Clinical significance of the blood copper in Hodgkin’s disease. Acta haemat. 24, 201 (1960).

    Article  PubMed  CAS  Google Scholar 

  • Paltauf, R.: Lymphosarcom. Ergebn. allgem. Path. path. Anat. 3, 652 (1896).

    Google Scholar 

  • Papillon, J., P. Croizat, L. Revol, J. L. Chassard, J. Feroldi, A. Contamin et L. Duton: Les survies de plus de 10 ans dans la maladie de Hodgkin. Nouv. Rev. franç. Haem. 6, 79 (1966).

    CAS  Google Scholar 

  • Papillon, J., P. Croizat, L. Revol, J. L. Chassard, J. Feroldi, A. Contamin et L. Duton, F. Bothier et J. Coste: Les localisations osseuses de la lymphogranulomatose maligne. J. Radiol. Électrol. 45, 109 (1964).

    PubMed  CAS  Google Scholar 

  • Parsons, P. B., and M. A. Poston: Pathology of human brucellosis; report of four cases with one autopsy. South. Med. J. 32, 7 (1939).

    Article  Google Scholar 

  • Paterson, E.: Evaluation of chemotherapeutic compounds in the reticuloses. Brit. J. Cancer 12, 332 (1958).

    Article  PubMed  CAS  Google Scholar 

  • Paterson, E., P. B. Kunkler, and A. L. Walpole: Triethylenemelamine in human malignant disease: results with oral administration of enteric-coated tablets. Brit. med. J. i, 59 (1953).

    Article  Google Scholar 

  • Pavero, A., e S. Della Pietra: L’impiego dell’indometacin nel trattamento della febbre nella linfogranulomatosi maligna. Arch. Maragl. 22, 541 (1966).

    CAS  Google Scholar 

  • Peters, M. V.: Hodgkin’s disease: radiation therapy. J. Amer. med. Ass. 191, 28 (1965).

    Article  CAS  Google Scholar 

  • Peters, M. V.: Prophylactic treatment of adjacent areas in Hodgkin’s disease. Canc. Res. 26, 1232 (1966).

    CAS  Google Scholar 

  • Peters, M. V., T.C. Brown, J.W. Davidson, V. S. Saxena, and M. Saini: The value of locating occult disease in the treatment of Hodgkin’s disease. Progress in Lymphology. Stuttgart: Thieme 1967.

    Google Scholar 

  • Peters, M. V., and K. Ch. Middlemiss: A study of Hodgkin’s disease treated by irradiation. Amer. J. Roentgenol. 79, 114 (1956).

    Google Scholar 

  • Piemonte, M.: Considerazioni terapeutiche sul linfogranuloma maligno. Lezioni sui tumori. Vol. IV, Udine 1965.

    Google Scholar 

  • Pinkel: Quoted by Storti.

    Google Scholar 

  • Pisani, G., e A. Malaspina: Le localizzazioni scheletriche del linfogranuloma maligno. Min. Med. 48, 2213 (1957).

    CAS  Google Scholar 

  • Ralston, L. S., and W. A. Wasdall: Gastrointestinal Hodgkin’s disease. Amer. J. Gastroent. 29, 537 (1958).

    PubMed  CAS  Google Scholar 

  • Ramioul, H.: Les differents aspects cliniques et radiologiques des localisations pulmonaires de la maladie de Hodgkin. Acta Clin. Belg. 15, 1 (1960).

    PubMed  CAS  Google Scholar 

  • Ranney, H. M., and A. Gellhorn: Effect of massive prednisone and prednisolone therapy on acute leukemia and malignant lymphomas. Amer. J. Med. 22, 405 (1957).

    Article  PubMed  CAS  Google Scholar 

  • Ratti, A.: La radioterapia endolinfatica con I131. Primi risultati. Rad. Clin. 31, 220 (1962).

    CAS  Google Scholar 

  • Reed, D.M.: On the pathological changes in Hodgkin’s disease with special references to its relation to tuberculosis. Johns Hopkins Hosp. Rep. 10, 133 (1902).

    Google Scholar 

  • Rigat, L.: Rendiconto clinico-statistico dei linfoblastomi maligni trattati del 1928 al 1949. II. Il linfogranuloma maligno. Rad. Med. 44, 438 (1958).

    CAS  Google Scholar 

  • Roos, D., and A. Videbaek: Prognosis in Hodgkin’s disease. Dan. med. Bull. 6, 177 (1959).

    Google Scholar 

  • Rosenberg, S. A., and H.S. Kaplan: Evidence for an orderly progression in the spread of Hodgkin’s disease. Canc. Res. 26, 1225 (1966).

    CAS  Google Scholar 

  • Rottino, A.: Therapeutic results in treatment of Hodgkin’s disease with CB 1348 and R 48. Blood 12, 755 (1957).

    PubMed  CAS  Google Scholar 

  • Rottino, A.: Triethylene melamine in treatment of Hodgkin’s disease and other lymphomas. N. Y. St. J. Med. 52, 346 (1952).

    CAS  Google Scholar 

  • Rottino, A., and A. Levy: Behaviour of total serum complement in Hodgkin’s disease and other malignant lymphomas. Blood 14, 246 (1959).

    PubMed  CAS  Google Scholar 

  • Rousselot, L. M., A. J. Rella, and A. Rottino: Splenectomy for hypersplenism in Hodgkin’s disease. Amer. J. Surg. 103, 769 (1962).

    Article  Google Scholar 

  • Rubin, P.: Hodgkin’s disease. J. Amer. med. Ass. 190, 910 (1964).

    Article  CAS  Google Scholar 

  • Rubin, P.: Hodgkin’s disease. Comment: pregnancy and childhood. J. Amer. med. Ass. 191, 318

    Google Scholar 

  • Rubin, P., and S. S. Kurohara: Has prophilactic irradiation proved itself in the treatment of localised Hodgkin’s disease? Radiol. 87, 240 (1966).

    CAS  Google Scholar 

  • Rundles, R. W., E.V. Conrad, and N. L. Willard: Summary of results obtained with TEM. Ann. N. Y. Acad. Sci. 68, 926 (1958).

    Article  PubMed  CAS  Google Scholar 

  • Samman, P.D.: Hodgkin’s disease: Cutaneous manifestations. Proc. roy. Soc. Med. 60, 736 (1966).

    Google Scholar 

  • Sampey, J. R.: Chemotherapeutic management of mycosis fungoides. A survey of 224 cases. Amer. J. Pharm. 131, 152 (1959).

    PubMed  CAS  Google Scholar 

  • Sartoris, S., C. Bachi, D. Blefari, P. Cavallero, F. Vergnano e N. Fazio: La metilidrazina nel trattamento del morbo di Hodgkin. Min. Med. 59, 296 (1968).

    CAS  Google Scholar 

  • Schamaun, M.: Chirurgische Behandlungsmöglichkeiten der Lymphogranulomatose. Praxis 55, 754 (1966).

    PubMed  CAS  Google Scholar 

  • Schamaun, M.: Surgical treatment of Hodgkin’s disease. Progress in Lymphology. Stuttgart: Thieme 1967.

    Google Scholar 

  • Schier, W. W.: Cutaneous anergy and Hodgkin’s disease. New Engl. J. Med. 250, 353 (1954).

    Article  PubMed  CAS  Google Scholar 

  • Schuller, L., I. Cojolan, I. Lörincz, S. Olarin, and T. Shapira: Primary malignant lymphogranulomatosis of the stomach associated with pregnancy. Oncología (Basel) 20, 291 (1966).

    CAS  Google Scholar 

  • Schwarz, G.: The role of lymphangiography. Hodgkin’s disease. J. Amer. med. Ass. 190, 912 (1964).

    Article  CAS  Google Scholar 

  • Scott, R. M., and M. E. Brizel: Time-dose relationships in Hodgkin’s disease. Radiology 82, 1043 (1964).

    PubMed  CAS  Google Scholar 

  • Sellei, C., and S. Eckhardt: Clinical observations with 1,6 bis(beta chloroethylamino)-1,6-deoxy-D-mannitol dihydrochloride (BCM) in malignant diseases. Ann. N. Y. Acad. Sci. 68, 1164 (1958).

    Article  PubMed  CAS  Google Scholar 

  • Shimkin, M. B.: Hodgkin’s disease: Effectiveness of treatment in control. J. Amer. med. Ass. 190, 916 (1964).

    Article  CAS  Google Scholar 

  • Shimkin, M. B., K. C. Oppermann, W. L. Bostick, and B. V. A. Low-Beer: Hodgkin’s disease: an analysis of frequency, distribution and mortality at the University of California Hospital 1914–1951. Ann. int. Med. 42, 137 (1955).

    Google Scholar 

  • Sicher, K., and T. W. Backhouse: Experiences with methylhydrazine. Brit. med. J. i, 858 (1965).

    Article  Google Scholar 

  • Silberman, H. R., T. G. MacGinn, and W. B. Kremer: Control of fever in Hodgkin’s disease by indometacin. J. Amer. med. Ass. 194, 597 (1965).

    Article  CAS  Google Scholar 

  • SilverBerg, J. H., and W. Dameshek: Use of triethylenemelamine in treatment of leukemia and leukosarcoma. J. Amer. med. Ass. 148, 1015 (1952).

    Article  CAS  Google Scholar 

  • Slaughter, D. P.: Hodgkin’s disease: radical surgery. J. Amer. med. Ass. 191, 26 (1965).

    Article  CAS  Google Scholar 

  • Slaughter, D. P., S. G. Economou, and H. W. Southwick: Surgical management of Hodgkin’s disease. Ann. Surg. 148, 705 (1958).

    Article  PubMed  CAS  Google Scholar 

  • Smetana, H. F., and B.M. Cohen: Mortality in relation to histologic type in Hodgkin’s disease. Blood 11, 211 (1956).

    PubMed  CAS  Google Scholar 

  • Smith, D. F., and C. T. Klopp: The value of surgical removal of localised lymphomas. Surg. 49, 469 (1961).

    Google Scholar 

  • Smith, R. S. W., Th. W. Sheey, and H. Rothberg: Hodgkin’s disease and pregnancy. Case report and discussion of the treatment of Hodgkin’s disease and leukemia during pregnancy. Arch. int. Med. 102, 777 (1958).

    Article  CAS  Google Scholar 

  • Sokal, J. E.: Immunologic unresponsiveness in Hodgkin’s disease. Canc. Res. 26, 1161 (1966).

    Google Scholar 

  • Spear, W.: The use of aminopyrine to control fever in Hodgkin’s disease. J. Amer. med. Ass. 180, 148 (1962).

    Article  Google Scholar 

  • Stacher, A.: Ergebnisse der zytostatischen Therapie maligner Hämatoblastosen. Wien. 2. inn. Med. 47, 1 (1966).

    CAS  Google Scholar 

  • Sternberg, C.: Ueber eine eigenartige unter dem Bilde der Pseudoleukämie verlaufende Tuberkulose des lymphatischen Apparates. 2. Heilk. 19, 21 (1898).

    Google Scholar 

  • Stolberg, H. D., N. L. Patt, K. F. MacEven, O. H. Warwick, and T. C. Brown: Hodgkin’s disease of the lung: roentgenologic-pathologic correlation. Amer. J. Roentgenol. 92, 96 (1964).

    PubMed  CAS  Google Scholar 

  • Storti, E.: Peut-on considérer la lymphogranulomatose comme une maladie à debut localisé? Necessité d’un diagnostic précis. Soc. Med. Paris 754 (1937).

    Google Scholar 

  • Storti, E., e S. Perugini: La terapia del linfogranuloma maligno nella pratica. Arch. Med. Mutual. 44 (1965).

    Google Scholar 

  • Stramignoni, A., V. Canino e F. Mollo: Aspetti morfologici della malattia di Hodgkin con riferimento alla prognosi. Giorn. Accad. Med. Torino 130, 259 (1967).

    Google Scholar 

  • Stutzman, L., E. B. E.Z. Diuli, and M. A. Stutzman: Vinblastine sulfate versus cyclophosphamide in the therapy for lymphoma. J. Amer. med. Ass. 195, 173 (1966).

    Article  CAS  Google Scholar 

  • Svoboda, G. H.: Current status of research on the alkaloids of vinca rosea linn. Antitumoral effect of Vinca Rosea alkaloids. Amsterdam: Excerpta Med. Found. 1966.

    Google Scholar 

  • Syke, P. et al.: Quoted by Marchal.

    Google Scholar 

  • Teitelman, Lloyd S., and N. R. Brill: Localised Hodgkin’s disease of the small intestine. Amer. J. Surg. 69, 247 (1960).

    Article  Google Scholar 

  • Todd, I. D. H.: Intracranial lesions in Hodgkin’s disease. Proc. roy. Soc. Med. 60, 734 (1966).

    Google Scholar 

  • Todd, D.M.: A methylhydrazine derivative (Ro 4–6467) in the management of late Hodgkin’s disease and other lymphoreticular neoplasms. Brit. Med. J. i, 628 (1965).

    Article  Google Scholar 

  • Torricelli, A., e G. Canossi: Considerazioni su di un caso di linfogranuloma maligno con localizzazioni osteosclerotiche al rachide (vertebra d’avorio) e al bacino. Ann. Radiol. Diagn. 32, 1 (1959).

    PubMed  CAS  Google Scholar 

  • Trousseau: Quoted by Chevallier et Bilski-Pasquier.

    Google Scholar 

  • Tubiana, M.: Tendences nouvelles dans la radiothérapie de la maladie de Hodgkin. Oncologia 20, suppl. 4 (1966).

    Article  Google Scholar 

  • Tubiana, M., A. J. Laugier, M. J. Schlienger et G. Juillard: La radiotherapie de la maladie de Hodgkin. Rev. Pract. 16, 911 (1966).

    CAS  Google Scholar 

  • Tubiana, M., A. J. Laugier, M. Hayat, E. Attie et G. Mathé: Essai d’association radiotherapie-chimiothérapie dans le traitement de la maladie de Hodgkin. Nouv. Rev. Franc. Hémat. 6, 134 (1966).

    PubMed  CAS  Google Scholar 

  • Uehlinger, E.: Über Knochenlymphogranulomatose. Virch. Arch. 288, 36 (1933).

    Article  Google Scholar 

  • Ultmann, J. E.: Chemioterapia del linfoma. Aggiorn. Emat. 3, 203 (1966).

    Google Scholar 

  • Ultmann, J. E., J. K. Cunningham, and A. Gellhorn: The clinical picture of Hodgkin’s disease. Canc. Res. 26, 1047 (1966).

    CAS  Google Scholar 

  • Ultmann, J. E., G. A. Hyman, Ch. Crandall, H. Naujoks, and A. Gellhorn: Triethylenethiophosphoramide (Thio-TEPA) in the treatment of neoplastic disease. Cancer 10, 903 (1957).

    Article  Google Scholar 

  • Ultmann, J. E., G. A. Hyman, Ch. Crandall, H. Naujoks, and A. Gellhorn: Chlorambucil in treatment of chronic lymphocytic leukemia and certain lymphomas. J. Amer. med. Ass. 162, 178 (1956).

    Article  Google Scholar 

  • Vaitkevicius, V. K., R. W. Talley, J.L. Tucker, and M. J. Brennan: Cytological and clinical observations during vincaleucoblastine therapy of disseminated cancer. Cancer 15, 294 (1962).

    Article  Google Scholar 

  • Virieux, C.: Evolution de la maladie de Hodgkin associée à une grossesse. Rev. Méd Suisse Rom. 86, 821 (1966).

    PubMed  CAS  Google Scholar 

  • Wagner, K., H. Haas u. A. Meyerhold: Erfahrungen mit Natulan. Behandlung von Lymphogranulomatosen und Retikulosarcomatosen. Wien. klin. Wschr. 36, 589 (1965).

    Google Scholar 

  • Wagner, O.: Die Eosinophilie und das Hautjucken bei Lymphogranulomatose. Schweiz. med. Wschr. 78, 745 (1948).

    PubMed  CAS  Google Scholar 

  • Warwick, O. H., R. E. Alison, and J. M. Darte: Clinical experience with vinblastine sulfate. Canad. med. Ass. J. 85, 579 (1961).

    PubMed  CAS  Google Scholar 

  • Weitzel, G., F. Schneider u. A. M. Fretzdorff: Cytostatischer Wirkungsmechanismus der Methylhydrazine. Experientia 20, 38 (1964).

    Article  PubMed  CAS  Google Scholar 

  • West, W. O., and B. A. Bouroncle: Spontaneous perforation of the oesophagus in Hodgkin’s disease. Report of three cases and literature review. Amer. J. Gastroent. 33, 335 (1960).

    PubMed  CAS  Google Scholar 

  • Westling, P.: Studies on the prognosis in Hodgkin’s disease. Acta radiol. Suppl. 245, (1965).

    Google Scholar 

  • Whitelaw, D. M., and J. M. Teasdale: Vincaleucoblastine in the treatment of malignant disease. Canad. med. Ass. J. 85, 584 (1961).

    PubMed  CAS  Google Scholar 

  • Williams, H. M., H. D. Diamond, L. F. Craver, and H. Parsons: Neurological complications of lymphomas and leukemias. Springfield, Ill.: Thomas 1959.

    Google Scholar 

  • Williams, R. D., N. C. Andews, and R. P. Zanes: Major surgery in Hodgkin’s disease. Surg. Gyn. Obst. 93, 636 (1951).

    PubMed  CAS  Google Scholar 

  • Wilkinson, J. F.: The chemotherapeutic treatment of the reticuloses. Proc. roy. Soc. Med. 48, 365 (1955).

    PubMed  CAS  Google Scholar 

  • Wilkinson, J. F., M. S. Bourne, and M. C. G. Israels: Treatment of leukemias and reticulosis with uracil mustard. Brit. med. J. i, 1563 (1963).

    Article  Google Scholar 

  • Wilks, S.: Cases of enlargement of the lymphatic glands and spleen. Guy’s Hosp. Report 11, 56 (1865).

    Google Scholar 

  • Wise, N. B., and M. A. Poston: Coexistence of brucella infection and Hodgkin’s disease. J. Amer. med. Ass. 115, 1976 (1940).

    Article  Google Scholar 

  • Witte, S., H. Martin u. J. C. F. Schubert: Über die cytostatische Therapie mit einem Methylhydrazinderivat. Schweiz. med. Wschr. 96, 93 (1966).

    Google Scholar 

  • Witte, S., H. Martin u. K. Th. Schricker: Die zytostatische Therapie der Lymphogranulomatose. In Therapie maligner Tumoren, Hämoblastome und Hämoblastosen, Bd. I, Pathologie and Chemotherapie. Stuttgart: Enke 1966.

    Google Scholar 

  • Wright, C. I. E.: Hodgkin’s paragranuloma. Cancer 9, 773 (1956).

    Article  PubMed  CAS  Google Scholar 

  • Wright, C. I. E.: The “benign” form of Hodgkin’s disease (Hodgkin’s paragranuloma). J. Path. Bact. 80, 157 (1960).

    Article  PubMed  CAS  Google Scholar 

  • Wright, J. C., S. L. Gumpert, and F.M. Colomb: Remission produced with the use of Methothrexate in patients with mycosis fungoides. Canc. Chemotherap. Report 9, 11 (1960).

    CAS  Google Scholar 

  • Zeller, P., H. Gutmann, B. Hegedüs, A. Keiser, A. Langemann, and M. Müller: Methylhydrazine derivatives, a new class of cytotoxic agents. Experientia 19, 129 (1963).

    Article  PubMed  CAS  Google Scholar 

  • Ziegler, K.: Die Hodgkinsche Krankheit. Jena: Fischer 1911.

    Google Scholar 

  • Zographov, D. G.: Ein Beitrag zur Kasuistik der Lymphogranulomatose. Akute Lymphogranulomatose. Zschr. inn. Med. 16, 565 (1961).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Oncology, Torino, Italy

    Professor Dr. Enrico Anglesio (Head of Department of Hormone-Chemotherapy, Member effective of G.E.C.A. (Group Européen pour la Chimiothérapie Anticancereuse)

Authors
  1. Professor Dr. Enrico Anglesio
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1969 Springer-Verlag Berlin · Heidelberg

About this chapter

Cite this chapter

Anglesio, E. (1969). Clinical Management of Hodgkin’s Disease. In: The Treatment of Hodgkin’s Disease. Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, vol 18. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-48266-3_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-48266-3_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-48268-7

  • Online ISBN: 978-3-642-48266-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation